New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 15, 2017 – Mayne Pharmaceuticals announced the launch of AB-rated generic versions of Aqua Pharmaceuticals’ Acticlate (doxycycline hyclate) 75 mg and 150 mg tablets for the treatment of a number of bacterial infections.
Download PDF
Return to publications
